Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1128257

registered interest
date	24/05/2019
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Winter Fuel Payment: Maladministration
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, on how many occasions the winter fuel payment has been incorrectly paid; and what steps he has taken to recover those payments in each of the last three years.
tabling member constituency	Moray
tabling member printed	Douglas Ross
uin	257526
answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>The DWP makes around 12 million Winter Fuel payments each year.</p><p>The DWP is working hard to prevent overpayments from occurring in the first place. However, these do sometimes occur due to a claimant failing to inform DWP of a change of household composition, or that they have moved abroad. Winter Fuel staff annually undertake an extensive Data Matching exercise to identify if any overpayments have occurred, and reduce the possibility of incorrect payments.</p><p>The table below shows the volume of Winter Fuel payments that were overpaid in the last 3 financial years rounded to the nearest 100. This represents less than 0.05% of the total Winter Fuel payments made.</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Volume Of Winter Fuel Payments Overpaid</p></td></tr><tr><td><p>2016-17</p></td><td><p>3,600</p></td></tr><tr><td><p>2017-18</p></td><td><p>5,000</p></td></tr><tr><td><p>2018-19</p></td><td><p>5,200</p></td></tr></tbody></table><p><em>*The data in this response has been sourced from internal management information. It should therefore not be compared to any other similar data subsequently released by the Department.</em></p><p /><p>The DWP has an obligation to ensure that public money is administered responsibly. Therefore, where permitted under Social Security legislation, the DWP seeks to recover any overpaid benefit. Where possible, the DWP will recover through on-going deductions from a claimant’s benefit.</p><p>The DWP ensures that appropriate safeguards are in place to protect claimants who have deductions from their benefit to repay overpayments. There are maximum rates of deduction that are set out in legislation, and if a claimant is struggling they can contact the DWP’s Debt Management Team to discuss lowering their repayment rate.</p><p> </p> answering member constituency Hexham answering member printed Guy Opperman question first answered 10/06/2019 15:06:10 answering member 4142 label Biography information for Guy Opperman
tabling member	4627 label Biography information for Douglas Ross

1128437

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether (a) NICE and (b) NHS England take into account the availability of medicines under the Early Access to Medicines Scheme when assessing those same medicines for approval as new medicines.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	257759
answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>The National Institute for Health and Care Excellence takes into account the availability of medicines through the Early Access to Medicines Scheme (EAMS) in terms of scheduling its assessments, however the process followed in assessing the technology is the same as for non-EAMS technologies.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 07/06/2019 14:54:05 answering member 4455 label Biography information for Seema Kennedy
tabling member	4398 label Biography information for Chris Green

1128438

registered interest
date	23/05/2019
answering body	Department for Digital, Culture, Media and Sport
answering dept id	10
answering dept short name	Digital, Culture, Media and Sport
answering dept sort name	Digital, Culture, Media and Sport
hansard heading	5G
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Digital, Culture, Media and Sport, whether he plans to request information from mobile operators on the localised effects of the installation of 5G on (a) people and (b) the natural environment.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	257637
answer	answer is ministerial correction date of answer 06/06/2019 answer text <p>We are committed to becoming a world leader in 5G, and for the majority of the population to have access to a 5G signal by 2027. Following the Future Telecoms Infrastructure Review which sets out the Government’s national, long-term strategy for delivering world leading telecoms infrastructure across the UK, the Government is working to create the right conditions for the deployment of 5G.</p><p> </p><p>Ministers have regular discussions with Mobile Network Operators on a full range of subjects relating to mobile coverage and future digital infrastructure development, including 5G. Specific issues relating to health concerns and the natural environment are the responsibility of DHSC/Public Health England (PHE) and DEFRA respectively.</p><p> </p><p>A considerable amount of research has been carried out on radio waves and we anticipate no negative effects on public health.</p><p>PHE’s Centre for Radiation, Chemical and Environmental Hazards (CRCE) takes the lead on public health matters associated with radiofrequency electromagnetic fields, or radio waves, used in telecommunications.</p><p>Central to PHE advice is that exposures to radio waves should comply with the guidelines published by the International Commission on Non-Ionizing Radiation Protection (ICNIRP). ICNIRP is formally recognised by the World Health Organization (WHO).</p> answering member constituency Stourbridge answering member printed Margot James question first answered 06/06/2019 15:06:21 answering member 4115 label Biography information for Margot James
tabling member	252 label Biography information for Dr David Drew

1128440

registered interest
date	23/05/2019
answering body	Department for Digital, Culture, Media and Sport
answering dept id	10
answering dept short name	Digital, Culture, Media and Sport
answering dept sort name	Digital, Culture, Media and Sport
hansard heading	5G: Defence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Digital, Culture, Media and Sport, what discussions he has had with the Secretary of State for Defence on the potential military applications of 5G technology.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	257638
answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>Ministers have regular discussions with their Cabinet colleagues on a wide range of issues, but have not discussed the specific issue of the potential military applications of 5G technology.</p> answering member constituency Stourbridge answering member printed Margot James question first answered 10/06/2019 11:04:32 answering member 4115 label Biography information for Margot James
tabling member	252 label Biography information for Dr David Drew

1128441

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the accuracy of evidence base on the cost-effectiveness of medical cannabis.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	257705
answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>An initial impact assessment was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. This can be viewed at the following link:</p><p><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></p><p>This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of cannabis-based products for medicinal use (CBPM). This framework included potential savings in treatment costs, giving the example of patients with severe epilepsy for whom medicinal use of cannabis could reduce the frequency of seizures and reduce the number of related hospital admissions. This was an initial framework for assessing this policy and as we develop our knowledge in this area, both on the costs and the potential benefits, we can revisit and refine these assessments.</p><p>In the meantime, the National Institute for Health and Care Excellence (NICE) is developing clinical guidelines on the appropriate use of CBPM based on the best available evidence, and the National Institute for Health Research is funding further clinical research on this. More information is available at the following link:</p><p><a href="https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf" target="_blank">https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 13:23:02 answering member 4455 label Biography information for Seema Kennedy
tabling member	1528 label Biography information for Sir Mike Penning

1128442

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the evidence (a) his Department and (b) the Department for International Trade holds on growing a market for prescribed medicinal cannabis.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	257706
answer	answer is ministerial correction date of answer 10/06/2019 answer text <p><ins class="ministerial"> <p><ins class="ministerial">The Department for International Trade and the Department of Health and Social Care are not specifically collecting data on the growth of the market for cannabis based products for medicinal use in the United Kingdom.</ins></p><p><ins class="ministerial">However, data from the Medicines and Healthcare products Regulatory Agency (MHRA) shows growing numbers of import notifications for medicinal cannabis and the Home Office has received increased numbers of licence applications.</ins></p><p><ins class="ministerial">In addition, UK companies exporting these products and foreign companies looking to invest in the UK have full access to government support, where they have the necessary authorisations from the MHRA and Home Office and a relevant Export Licence.</ins></p></ins></p><p><del class="ministerial">An initial impact assessment was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. This can be viewed at the following link:</del></p><p><del class="ministerial"><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></del></p><p><del class="ministerial">This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of cannabis-based products for medicinal use (CBPM). This framework included potential savings in treatment costs, giving the example of patients with severe epilepsy for whom medicinal use of cannabis could reduce the frequency of seizures and reduce the number of related hospital admissions. This was an initial framework for assessing this policy and as we develop our knowledge in this area, both on the costs and the potential benefits, we can revisit and refine these assessments.</del></p><p><del class="ministerial">In the meantime, the National Institute for Health and Care Excellence (NICE) is developing clinical guidelines on the appropriate use of CBPM based on the best available evidence, and the National Institute for Health Research is funding further clinical research on this. More information is available at the following link:</del></p><p><del class="ministerial"><a href="https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf" target="_blank">https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf</a></del></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 13:18:03 question first ministerially corrected 11/06/2019 11:31:21 answering member 4455 label Biography information for Seema Kennedy previous answer version 121340 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1528 label Biography information for Sir Mike Penning

1128443

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the interim report produced by NHS England to identify the barriers that are blocking access to prescribed medicinal cannabis by patients.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	257707
answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>The NHS England process review is underway and interviews are scheduled to take place over June 2019. The interim report will not be published, as by its nature any findings will be incomplete. The Government is, however, committed to publishing a summary of the final findings and recommendations before summer recess.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 257708 question first answered 07/06/2019 14:49:30 answering member 4455 label Biography information for Seema Kennedy
tabling member	1528 label Biography information for Sir Mike Penning

1128444

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the final report by NHS England to identify the barriers that are blocking access to prescribed medicinal cannabis by patients.
tabling member constituency	Hemel Hempstead
tabling member printed	Sir Mike Penning
uin	257708
answer	answer is ministerial correction date of answer 07/06/2019 answer text <p>The NHS England process review is underway and interviews are scheduled to take place over June 2019. The interim report will not be published, as by its nature any findings will be incomplete. The Government is, however, committed to publishing a summary of the final findings and recommendations before summer recess.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 257707 question first answered 07/06/2019 14:49:30 answering member 4455 label Biography information for Seema Kennedy
tabling member	1528 label Biography information for Sir Mike Penning

1128451

registered interest
date	23/05/2019
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Antisocial Behaviour
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what assessment he has made of the effectiveness of the Community Trigger process in the Anti-Social Behaviour, Crime and Policing Act 2014.
tabling member constituency	Bristol South
tabling member printed	Karin Smyth
uin	257769
answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>We keep anti-social behaviour policy under review through a National Anti-social Behaviour Strategic Board which brings together a range of partners and representatives from key agencies, including the police, local government, and other Government departments, to consider the effectiveness of the powers introduced in the Anti-social Behaviour, Crime and Policing Act 2014. We also published refreshed statutory guidance for frontline professionals on the use of these powers on 24 December 2017.</p><p>We are aware of the Victims’ Commissioner’s report on anti-social behaviour, published on 30 April, and which makes several recommendations, including on improvements to the Community Trigger process. We will carefully <br>consider the findings and recommendations in this report.</p> answering member constituency Louth and Horncastle answering member printed Victoria Atkins grouped question UIN 257770 question first answered 10/06/2019 12:03:33 answering member 4399 label Biography information for Victoria Atkins
tabling member	4444 label Biography information for Karin Smyth

1128452

registered interest
date	23/05/2019
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Antisocial Behaviour
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what assessment he has made of the level of compliance by local authorities with the requirement under the Anti-Social Behaviour, Crime and Policing Act 2014 to publish data on their use of Community Triggers.
tabling member constituency	Bristol South
tabling member printed	Karin Smyth
uin	257770
answer	answer is ministerial correction date of answer 10/06/2019 answer text <p>We keep anti-social behaviour policy under review through a National Anti-social Behaviour Strategic Board which brings together a range of partners and representatives from key agencies, including the police, local government, and other Government departments, to consider the effectiveness of the powers introduced in the Anti-social Behaviour, Crime and Policing Act 2014. We also published refreshed statutory guidance for frontline professionals on the use of these powers on 24 December 2017.</p><p>We are aware of the Victims’ Commissioner’s report on anti-social behaviour, published on 30 April, and which makes several recommendations, including on improvements to the Community Trigger process. We will carefully <br>consider the findings and recommendations in this report.</p> answering member constituency Louth and Horncastle answering member printed Victoria Atkins grouped question UIN 257769 question first answered 10/06/2019 12:03:33 answering member 4399 label Biography information for Victoria Atkins
tabling member	4444 label Biography information for Karin Smyth